Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Closure of the Ductus Arteriosus in Premature Infants by Inhibition of Prostaglandin Synthesis
1976 • 505 citations
Pharmacologic Closure of Patent Ductus Arteriosus in the Premature Infant
1976 • 500 citations
Effect of Fluid Administration on the Development of Symptomatic Patent Ductus Arteriosus and Congestive Heart Failure in Premature Infants
1980 • 347 citations
Prophylactic Indomethacin Therapy for Patent Ductus Arteriosus in Very-Low-Birth-Weight Infants
1982 • 182 citations
Medical management of small preterm infants with symptomatic patient ductus arteriosus
1978 • 160 citations
Incidence and Clinical Features of Patent Ductus Arteriosus in Low-Birthweight Infants: A Prospective Analysis of 150 Consecutively Born Infants
1976 • 141 citations
Pharmacokinetics of Indomethacin in the Neonate
1981 • 140 citations
Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus—a double-blind controlled study
1981 • 137 citations
Early closure of the patent ductus arteriosus in very low-birth-weight infants: A controlled trial
1981 • 129 citations
Fluid administration in the association of patent ductus arteriosus complicating respiratory distress syndrome
1977 • 115 citations
Failure of indomethacin to close persistent ductus arteriosus in infants weighing under 1000 grams.
1979 • 61 citations
Indomethacin Treatment for Symptomatic Patent Ductus Arteriosus: A Double-Blind Control Study
1981 • 59 citations
Specificity and accuracy of echocardiographic and clinical criteria for diagnosis of patent ductus arteriosus in fluid-restricted infants
1981 • 44 citations
Pharmacological closure of ductus arteriosus in preterm infants using indomethacin
1980 • 34 citations
Parenteral Indomethacin for Closure of the Patent Ductus Arteriosus
1982 • 23 citations